Physician profile
Muhammad Akram
NPI 1902803737
$15,474.67
in general payments reported to CMS, 2019-2025
35 companies · $1,613 in 2025
The $1,613 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,185 · 2020: $202 · 2021: $212 · 2022: $620 · 2023: $5,249 · 2024: $3,394 · 2025: $1,613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,468 · Food and Beverage: $3,708 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,468.04 |
| Food and Beverage | $3,708.30 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $10,054.26 | 2019-2025 | Amplatzer Amulet, Aveir, Jot Dx |
| Medtronic, INC. | $2,250.67 | 2023-2025 | Arctic Front Advance, Pulseselect, Na |
| Novartis Pharmaceuticals Corporation | $790.38 | 2019-2025 | |
| Amgen INC. | $372.70 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $318.60 | 2020-2025 | Lifevest |
| Pfizer INC. | $246.50 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $241.67 | 2019-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $158.48 | 2020-2024 | |
| E.R. Squibb & Sons, L.L.C. | $143.28 | 2019-2024 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals Lp | $92.06 | 2022-2023 | Brilinta |
| Ethicon US, LLC | $91.64 | 2022-2024 | Surgicel Nu-Knit, Vistaseal, Dermabond Prineo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.38 | 2023-2024 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $74.45 | 2019-2022 | |
| Atricure, INC. | $60.04 | 2019-2023 | |
| Boston Scientific Corporation | $57.42 | 2024-2025 | Bodyguardian, Cds - Mct/Cem Monitoring |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $48.10 | 2024 | Barostim Neo System |
| Philips North America LLC | $43.56 | 2023 | |
| Baxter Healthcare | $38.01 | 2022-2024 | Hillrom - Carnation Ambulatory Monitor |
| Elutia, INC. | $37.53 | 2025 | Ecm Patch,Pouch |
| Inspire Medical Systems, INC. | $28.65 | 2023-2024 | Inspire |
| Angiodynamics, INC. | $24.29 | 2023 | Auryon Laser System 100-120 Vac |
| Averitas Pharma INC. | $23.71 | 2025 | Qutenza |
| Alnylam Pharmaceuticals INC. | $19.67 | 2024 | Onpattro |
| United Therapeutics Corporation | $18.43 | 2023 | Tyvaso |
| Astellas Pharma US INC | $18.27 | 2019 | |
| Siemens Medical Solutions USA, INC. | $17.21 | 2024 | Cios Spin |
| Electromed, INC. | $16.49 | 2023 | Smartvest |
| Terumo Medical Corporation | $16.43 | 2022 | |
| Scpharmaceuticals INC. | $15.69 | 2023 | |
| Novo Nordisk INC | $14.53 | 2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $14.07 | 2023 | Arcalyst |
| Merck Sharp & Dohme LLC | $13.91 | 2023 | |
| Amarin Pharma, INC. | $11.98 | 2021 | |
| Braemar Manufacturing, LLC | $11.06 | 2019 | |
| Kls-Martin L.P. | $8.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Akram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.